Last reviewed · How we verify
Osvaren film-coated tablets — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Osvaren film-coated tablets (Osvaren film-coated tablets) — Fresenius Medical Care Deutschland GmbH.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Osvaren film-coated tablets TARGET | Osvaren film-coated tablets | Fresenius Medical Care Deutschland GmbH | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Osvaren film-coated tablets CI watch — RSS
- Osvaren film-coated tablets CI watch — Atom
- Osvaren film-coated tablets CI watch — JSON
- Osvaren film-coated tablets alone — RSS
Cite this brief
Drug Landscape (2026). Osvaren film-coated tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/osvaren-film-coated-tablets. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab